fluciclovine-f-18 and Breast-Neoplasms--Male

fluciclovine-f-18 has been researched along with Breast-Neoplasms--Male* in 1 studies

Other Studies

1 other study(ies) available for fluciclovine-f-18 and Breast-Neoplasms--Male

Article	Year
Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan. Clinical nuclear medicine, 2018, Volume: 43, Issue:1 Prostate imaging with F-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC, F-fluciclovine) PET/CT scan (Axumin) was recently approved by the US Food and Drug Administration for men with suspected prostate cancer recurrence based on elevated blood prostate-specific antigen levels following prior treatment. We present a rare case of a 77-year-old man with suspected recurrent prostate cancer with an incidental finding of advanced-stage breast cancer showing different degrees of F-fluciclovine uptake. Topics: Aged; Biological Transport; Breast Neoplasms, Male; Carboxylic Acids; Cyclobutanes; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence	2018

Article

Year

Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.

Clinical nuclear medicine, 2018, Volume: 43, Issue:1

Prostate imaging with F-labeled 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC, F-fluciclovine) PET/CT scan (Axumin) was recently approved by the US Food and Drug Administration for men with suspected prostate cancer recurrence based on elevated blood prostate-specific antigen levels following prior treatment. We present a rare case of a 77-year-old man with suspected recurrent prostate cancer with an incidental finding of advanced-stage breast cancer showing different degrees of F-fluciclovine uptake.

Topics: Aged; Biological Transport; Breast Neoplasms, Male; Carboxylic Acids; Cyclobutanes; Humans; Incidental Findings; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence

2018